THOMAS HAUGHEY
CIK 1272247 · President · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.94M
Companies
3
Total Filings
46
Lifetime Open-Market Net
-$7.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 40,878 | $71.92 | $2.94M | -$1.50M | 10 | 2026-06-10 |
| ANI PHARMACEUTICALS INC (FOLD) Delisted | Director | 6,291 | $14.49 | $91.2K | $173.2K | 3 | 2019-05-15 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | President | 70,548 | — | — | -$6.29M | 30 | 2012-01-13 |
Recent Filings · Page 4 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-03-03 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | −15,258 | -$710.4K | EDGAR |
| 2010-01-12 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −3,622 | -$93.4K | EDGAR |
| 2010-01-06 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +12,631 | $0 | EDGAR |
| 2009-12-22 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −2,033 | -$52.9K | EDGAR |
| 2009-08-26 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Sell (S) | −31,000 | -$632.0K | EDGAR |
| 2009-03-24 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −2,359 | -$26.4K | EDGAR |
| 2009-01-14 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −1,017 | -$12.8K | EDGAR |
| 2009-01-12 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Mixed | −4,483 | -$58.8K | EDGAR |
| 2008-12-23 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Tax (F) | −2,033 | -$25.3K | EDGAR |
| 2008-11-20 | PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | Grant (A) | +45,496 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.